Walsh and Wilkinson
Paul Weiss litigation partners Beth Wilkinson and Alexandra Walsh were part of a team that recently achieved a victory for Pfizer Inc. when a federal court granted the company’s motion for summary judgment. The U.S. District Court for the Southern District of New York ruling in In Re Pfizer Inc. Securities Litigation dismissed the securities class action case in its entirety, according to the firm. The litigation involved decade-old disclosures related to Celebrex and Bextra.
“This was a major victory after a decade-long fight against these allegations,” Walsh told WIPL. “We are extremely gratified that the court recognized the fundamental deficiencies in the plaintiffs’ claims and dismissed the case before trial.”